Herbelin, A <br/><br/>
In vivo soluble tumor necrosis factor receptor release in OKT3-treated patients. Differential regulation of TNF-sR55 and TNF-sR75.  [electronic resource] 

 -  Transplantation  May 1995 
 - 1470-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199505270-00019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--pharmacology<br/>Antibodies, Monoclonal--therapeutic use<br/>Antilymphocyte Serum--pharmacology<br/>Biological Availability<br/>Enzyme-Linked Immunosorbent Assay<br/>Graft Rejection--prevention & control<br/>Humans<br/>Kidney Transplantation--immunology<br/>Receptors, Tumor Necrosis Factor--metabolism<br/>Solubility<br/>Tumor Necrosis Factor-alpha--immunology